Triesence (triamcinolone acetonide injectable suspension) - Novartis
Ozurdex (dexamethasone intravitreal implant) - AbbVie
Eylea (aflibercept intravitreal) - Bayer, Regeneron
Beovu (brolucizumab-dbll) - Novartis
Yutiq (fluocinolone acetonide intravitreal implant) - EyePoint Pharma
Avastin (bevacizumab) - Roche
Iluvien (fluocinolone acetonide) - Alimera Sci, EyePoint Pharma
Lucentis (ranibizumab) - Roche, Novartis
https://www.arvo.org/globalassets/annual-meeting/arvo-2021/arvo-2021-abstracts.pdf
 
A. Miller; A. Yazi; E. Petrinec; M. Carbone; C. Miller; E. R. Malik; C. McCrossin; D. G. Miller
 
May 13, 2021
 
Prev Next